Jennifer Tittensor, MD
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $13,600 of the $22,500 with a category attached, or 60.4%. Axogen accounts for 88.4% of it on its own, with 25 other manufacturers making up the rest. 2025 is the largest year on record at $17,817, more than ten times the $151 reported in 2019.
Across 122 payments — averaging $184.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Axogen$20K
- Davol Inc.$903
- Integra Lifesciences Corporation$652
- Johnson & Johnson$357
- Medical Device Business Services, Inc.$131
- Merck$91
- plus $472 from 20 others
What the payments were for
- Speaking & faculty fees$13,60060%
- Travel & lodging$4,35619%
- Food & beverage$3,89217%
- Other$6523%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Axogen | 30 | $19,894 |
| Davol Inc. | 37 | $903 |
| Integra Lifesciences Corporation | 1 | $652 |
| Johnson & Johnson | 20 | $357 |
| Medical Device Business Services, Inc. | 1 | $131 |
| Merck | 5 | $91 |
| KUB Technologies Inc. | 2 | $41 |
| Medtronic | 3 | $41 |
| Myriad Genetic Laboratories, Inc. | 2 | $39 |
| Covidien LP | 2 | $33 |
| Innovation Technologies Inc | 2 | $33 |
| Baxter Healthcare | 1 | $30 |
| Acell, Inc. | 2 | $27 |
| Elucent Medical | 1 | $27 |
| Hologic Inc | 2 | $26 |
| Dilon Technologies, Inc. | 1 | $23 |
| Solventum Corporation | 1 | $20 |
| Impedimed, Inc. | 1 | $19 |
| Focal Therapeutics, Inc. | 1 | $17 |
| Portola Pharmaceuticals, LLC | 1 | $17 |
| Gilead | 1 | $16 |
| BD | 1 | $16 |
| Hologic Sales And Service, LLC | 1 | $15 |
| Leica Microsystems Inc. | 1 | $12 |
| Tactile Systems Technology Inc | 1 | $12 |
| Baudax Bio Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AXOGUARD$34,591
- AXOGUARD HA+ NERVE PROTECTOR$19,547
- AxoGuard Nerve Cap$19,547
- AVANCE NERVE GRAFT$2,252
- AxoGuard Nerve Connector$2,252
- AxoGuard Nerve Protector$2,252
- DuraSorb Monofilament Mesh$652
- VISTASEAL$131
How this compares
$22,500 in reported general payments places this provider in the 85th percentile of 202 surgery providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 44 | $74 |
| Cephalexin | 15 | $67 |
Paid to pharmacies, not to this prescriber.
Other surgery in Provo
- R RasmussenProvo$79K
- Bruce HillProvo$23K
- John WennergrenProvo$21K
- Gregory PeirceProvo$11K
- Craig CookProvo$10K
- Jorge de Amorim FilhoSalt Lake City$344K
- Daniel CottamSalt Lake City$294K
- Mark MawhinneySalt Lake City$169K
- Nathan RichardsSalt Lake City$162K
- Cabot MurdockRiverton$161K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.